Clinical Trial of Immunotherapy for Basal Cell Carcinoma Shows Promise
According to a press release from Verrica Pharmaceuticals and its partner Lytix Pharmaceutical via Healio, results of Part 1 of the phase 2 study of their investigational therapy candidate VP…